Crinetics Pharmaceuticals, Inc. (CRNX) Free cash flow 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$383.7MFY2025 · since FY2016: -$5.7M → -$383.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$383.7M | -63.9% |
| FY2024 | -$234.0M | -35.1% |
| FY2023 | -$173.3M | -48.3% |
| FY2022 | -$116.9M | -31.3% |
| FY2021 | -$89.0M | -43.1% |
| FY2020 | -$62.2M | -32.7% |
| FY2019 | -$46.9M | -128.4% |
| FY2018 | -$20.5M | -109.7% |
| FY2017 | -$9.8M | -72.9% |
| FY2016 | -$5.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice